NCT06581822View on ClinicalTrials.gov

Biomarkers for Pharmacoresponse in Bipolar Disorder - Coagulation

Active, not recruitingOBSERVATIONAL
Enrollment

68

Participants

Timeline

Start Date

February 24, 2017

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2025

Conditions
Bipolar Disorder
Trial Locations (1)

17176

Karolinska Institutet, Stockholm

All Listed Sponsors
lead

Karolinska Institutet

OTHER

NCT06581822 - Biomarkers for Pharmacoresponse in Bipolar Disorder - Coagulation | Biotech Hunter | Biotech Hunter